Hua Zhou

1.5k total citations
27 papers, 615 citations indexed

About

Hua Zhou is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Hua Zhou has authored 27 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Hua Zhou's work include Chemical Synthesis and Analysis (4 papers), CAR-T cell therapy research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Hua Zhou is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), CAR-T cell therapy research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Hua Zhou collaborates with scholars based in China, United States and Canada. Hua Zhou's co-authors include Jifeng Wu, Leilei Shi, Xun Li, Huaiyu Zhou, Wei Hu, Xun Li, David Askin, Yong‐Li Zhong, Donald R. Gauthier and Jaemoon Lee and has published in prestigious journals such as Scientific Reports, Neuroscience and The Journal of Organic Chemistry.

In The Last Decade

Hua Zhou

26 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Zhou China 14 376 122 82 66 45 27 615
Yuki Takemoto Japan 16 661 1.8× 240 2.0× 66 0.8× 32 0.5× 16 0.4× 45 950
Hachemi Kadri United Kingdom 12 415 1.1× 303 2.5× 73 0.9× 24 0.4× 73 1.6× 16 807
Allison L. Choy United States 14 544 1.4× 300 2.5× 70 0.9× 21 0.3× 48 1.1× 17 807
Justin S. Cisar United States 11 298 0.8× 321 2.6× 61 0.7× 11 0.2× 29 0.6× 15 643
Johan Wannberg Sweden 13 514 1.4× 229 1.9× 23 0.3× 42 0.6× 47 1.0× 26 683
Gurdip Bhalay United Kingdom 13 369 1.0× 217 1.8× 23 0.3× 9 0.1× 25 0.6× 30 568
Aarajana Shrestha South Korea 19 334 0.9× 330 2.7× 95 1.2× 16 0.2× 14 0.3× 35 627
Miaobo Pan China 12 94 0.3× 227 1.9× 110 1.3× 16 0.2× 41 0.9× 20 423
Shizhen Zhao China 13 272 0.7× 168 1.4× 45 0.5× 6 0.1× 107 2.4× 30 547
Mustafa Güzel Türkiye 14 177 0.5× 166 1.4× 67 0.8× 6 0.1× 9 0.2× 41 467

Countries citing papers authored by Hua Zhou

Since Specialization
Citations

This map shows the geographic impact of Hua Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Zhou more than expected).

Fields of papers citing papers by Hua Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Zhou. The network helps show where Hua Zhou may publish in the future.

Co-authorship network of co-authors of Hua Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Zhou. A scholar is included among the top collaborators of Hua Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Zhou. Hua Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wenqi, Jiajia Liu, Hua Zhou, et al.. (2024). The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer. Antiviral Research. 232. 106035–106035. 2 indexed citations
3.
Liu, Jiajia, Hua Zhou, Chunyang Sun, et al.. (2024). Improved antitumor effectiveness of oncolytic HSV-1 viruses engineered with IL-15/IL-15Rα complex combined with oncolytic HSV-1-aPD1 targets colon cancer. Scientific Reports. 14(1). 23671–23671. 3 indexed citations
4.
Li, Qiufen, et al.. (2023). Tryptophan alleviates chronic heat stress–induced impairment of antioxidant capacities, inflammatory response, and mitochondrial function in broilers. Tropical Animal Health and Production. 55(6). 425–425. 6 indexed citations
5.
Qiu, Jing, Fei Ye, & Hua Zhou. (2021). Automatic Verification Platform Based on RISC-V Architecture Microprocessor. 157–160. 2 indexed citations
6.
Tian, Chao, Jiajia Liu, Hua Zhou, et al.. (2021). Enhanced anti-tumor response elicited by a novel oncolytic HSV-1 engineered with an anti-PD-1 antibody. Cancer Letters. 518. 49–58. 30 indexed citations
7.
Methot, Joey L., Matthew Christopher, Hua Zhou, et al.. (2020). Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors. ACS Medicinal Chemistry Letters. 11(12). 2461–2469. 11 indexed citations
8.
Chen, Xu, Hao‐Jie Zhu, Rong Shen, et al.. (2018). IL-35 is a Protective Immunomodulator in Brain Ischemic Injury in Mice. Neurochemical Research. 43(7). 1454–1463. 13 indexed citations
9.
Shi, Leilei, Wei Hu, Jifeng Wu, et al.. (2018). Quinoxalinone as a Privileged Platform in Drug Development. Mini-Reviews in Medicinal Chemistry. 18(5). 392–413. 134 indexed citations
10.
Shi, Leilei, Jianfeng Zhou, Jifeng Wu, et al.. (2016). Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 24(8). 1840–1852. 38 indexed citations
11.
Xu, Zhongliang, Jiamei Guo, Zhenzhong Li, et al.. (2016). 2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5. European Journal of Medicinal Chemistry. 123. 309–316. 28 indexed citations
12.
Zhou, Hua, et al.. (2016). Oxazole: A Promising Building Block for the Development of Potent Antitumor Agents. Current Topics in Medicinal Chemistry. 16(30). 3582–3589. 14 indexed citations
13.
Xu, Zhongliang, Hua Zhou, Yingli Cao, et al.. (2014). 2,4,5-Trisubstituted thiazole derivatives: A novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase. European Journal of Medicinal Chemistry. 85. 27–42. 37 indexed citations
14.
Shi, Leilei, Qiang Wang, Haina Wang, et al.. (2013). Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors. Bioorganic & Medicinal Chemistry. 21(24). 7752–7762. 9 indexed citations
15.
Fischer, Christian, Susan L. Zultanski, Hua Zhou, et al.. (2012). Triazoloamides as potent γ-secretase modulators with reduced hERG liability. Bioorganic & Medicinal Chemistry Letters. 22(9). 3140–3146. 13 indexed citations
16.
Ding, Yan, Xuefei Hou, Li Chen, et al.. (2012). Protective action of tetramethylpyrazine on the medulla oblongata in rats with chronic hypoxia. Autonomic Neuroscience. 173(1-2). 45–52. 11 indexed citations
17.
Shi, Yuanyuan, Qiang Chen, Wenxing Yang, et al.. (2008). Endogenous hydrogen sulfide is involved in regulation of respiration in medullary slice of neonatal rats. Neuroscience. 156(4). 1074–1082. 38 indexed citations
18.
Zhou, Hua, et al.. (2006). Efficient Synthesis of Functionalized Pyrimidones via Microwave‐Accelerated Rearrangement Reaction.. ChemInform. 37(22). 1 indexed citations
19.
Zhong, Yong‐Li, Hua Zhou, Donald R. Gauthier, et al.. (2005). Practical and efficient synthesis of N-halo compounds. Tetrahedron Letters. 46(7). 1099–1101. 39 indexed citations
20.
Fan, Kristi, Donna M. Huryn, J. Steven Jacobsen, et al.. (2005). Molecular-modeling based design, synthesis, and activity of substituted piperidines as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(7). 1891–1894. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuki Takemoto Breakdown of academic impact, for papers by Hachemi Kadri Breakdown of academic impact, for papers by Allison L. Choy Breakdown of academic impact, for papers by Justin S. Cisar Breakdown of academic impact, for papers by Johan Wannberg Breakdown of academic impact, for papers by Gurdip Bhalay Breakdown of academic impact, for papers by Aarajana Shrestha Breakdown of academic impact, for papers by Miaobo Pan Breakdown of academic impact, for papers by Shizhen Zhao Breakdown of academic impact, for papers by Mustafa Güzel
Rankless by CCL
2026